85226 Federal Register / Vol. 89, No. 207 / Friday, October 25, 2024 / Notices 

Health, 6701 Rockledge Drive, Room 1011–H, 

Bethesda, MD 20894, (301) 402–4341, 

thomascp@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Study In 

Cancer Biology Area Review. 

Date: November 15, 2024. 

Time: 11 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Charles Morrow, MD, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6202, 

MSC 7804, Bethesda, MD 20892, 301–408– 

9850, morrowcs@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; AREA/ 

REAP: Respiratory, Cardiac and Circulatory 

Sciences. 

Date: November 15, 2024. 

Time: 1 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Kirk E. Dineley, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 806E, 

Bethesda, MD 20892, (301) 867–5309, 

dineleyke@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: The Cancer Biotherapeutics 

Development (CBD). 

Date: November 18–19, 2024. 

Time: 9 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Laurie Ann Shuman Moss, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 867–5309, laurie.shumanmoss@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Clinical 

Data Management and Analysis/Clinical 

Informatics and Digital Health Special 

Emphasis Panel. 

Date: November 18–19, 2024. 

Time: 9 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Amy Kathleen Wernimont, 

BS, Ph.D., Scientific Review Officer, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6198, 

Bethesda, MD 20892, 301–827–6427, 

amy.wernimont@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Metabolic, Cerebrovascular, Environmental, 

and Sleep Factors in Alzheimer’s Disease and 

Related Dementias (ADRD). 

Date: November 18–19, 2024. 

Time: 9 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Jennifer Kielczewski, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 435–1042, jennifer.kielczewski@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: The Cancer Drug Development and 

Therapeutics (CDDT). 

Date: November 18–19, 2024. 

Time: 9 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Lilia Topol, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6192, 

MSC 7804, Bethesda, MD 20892, 301–451– 

0131, ltopol@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–22– 

180: Maximizing Investigators’ Research 

Award. 

Date: November 18, 2024. 

Time: 9:30 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Mollie Kim Manier, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 594–0510, mollie.manier@

nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

HIV/AIDS Intra- and Inter-personal 

Determinants and Behavioral Interventions 

Study Section. 

Date: November 18–19, 2024. 

Time: 10 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Mark P. Rubert, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, 301–806– 

6596, rubertm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 21, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–24878 Filed 10–24–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Center for Substance Abuse 

Prevention Drug Testing Advisory 

Board; Notice of Availability of Report 

of Fiscal Year 2023 Closed or Partially 

Closed Meetings 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: A report summarizing the 

closed or partially closed meeting 

activities of the SAMHSA’s Center for 

Substance Abuse Prevention Drug 

Testing Advisory Board during fiscal 

year 2023 has been prepared. A copy of 

this report has been filed with the 

Library of Congress. 

DATES: Applicable Date: This notice is 

applicable October 21, 2024. 

ADDRESSES: The report is available by 

contacting the DTAB designated federal 

official, Lisa Davis. 

FOR FURTHER INFORMATION CONTACT: Lisa 

Davis, Lisa.Davis@samhsa.hhs.gov. 

Phone: (240) 276–1440. 

SUPPLEMENTARY INFORMATION: There is a 

Departmental requirement to complete 

and submit an Annual Report on 

Federal advisory committees when an 

entire or portion of the meeting is closed 

to the public as required by Section 

10(d) of the Federal Advisory 

Committee Act (FACA). 

Copies of these reports for FY 2023 

are being submitted to the Library of 

Congress, FACA Desk for public 

inspection and use. 

Dated: October 21, 2024. 

Carlos Castillo, 

Committee Management Officer, SAMHSA. 

[FR Doc. 2024–24834 Filed 10–24–24; 8:45 am] 

BILLING CODE 4162–20–P 


ddrumheller on DSK120RN23PROD with NOTICES1